Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models
This review explores the crucial role of glycosphingolipids (GSLs) in the context of cardiovascular diseases (CVDs), focusing on their biosynthesis, metabolic pathways, and implications for clinical outcomes. GSLs are pivotal in regulating a myriad of cellular functions that are essential for heart...
Main Authors: | Sarah Huang, Karima Abutaleb, Sumita Mishra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/14/10/1265 |
Similar Items
-
Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
by: Jenni Huusko, et al.
Published: (2019-08-01) -
Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
by: Karolina Andrzejczyk, et al.
Published: (2024-06-01) -
Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
by: Stephanie J. Rowe, BBiomed, MD, et al.
Published: (2025-01-01) -
Heart failure: an update from the last years and a look at the near future
by: Mauro Riccardi, et al.
Published: (2022-12-01) -
Highlights in heart failure
by: Daniela Tomasoni, et al.
Published: (2019-12-01)